Add like
Add dislike
Add to saved papers

Back-calculation to model strategies for pretreatment adjustment of the ablation sphere in myopic wavefront laser in situ keratomileusis.

PURPOSE: To examine strategies for adjusting the ablation sphere in myopic wavefront laser in situ keratomileusis (LASIK) with reference to preoperative manifest refraction.

SETTING: Refractive Surgery Service, Moorfields Eye Hospital, London, United Kingdom.

METHODS: The variance in the 3-month postoperative manifest refraction spherical equivalent (MRSE) results in 295 consecutive cases of myopic wavefront LASIK treated with a nonsystematic, intuitive approach to pretreatment adjustment of the ablation sphere was compared with the variance in modeled results obtained by back-calculation using 4 systematic strategies: (1) no adjustment (No Adj), (2) addition of the difference between the preoperative MRSE and the preoperative 4.0 mm pupil wavefront refraction spherical equivalent (WRSE) (4.0 mm), (3) addition of the difference between the preoperative MRSE and the preoperative maximum pupil WRSE (Max), and (4) addition of the difference between the preoperative MRSE and the preoperative effective blur (EB). The EB is a theoretical value for the dioptric SE of all aberrations at the pupil size calculated for the Hartmann-Shack images acquired (wavefront diameter). A stratified analysis of results for different wavefront diameters was also performed.

RESULTS: Variance in the postoperative MRSE was least (0.116) when nonsystematic, intuitive adjustments to the ablation sphere were used. In ascending order, the back-calculated variance was as follows: EB (0.142; P = .09, Bartlett test), 4.0 mm pupil (0.163; P = .004), No Adj (0.171; P = .001), and Max (0.225; P<.0001). There was a strong trend toward reduced variance in results in patients with a larger wavefront diameter.

CONCLUSION: Back-calculation to model results with different pretreatment ablation adjustment strategies may be useful to eliminate unpromising new approaches before clinical trials.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app